A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G

Published 2020 View Full Article

Authors

Keywords

Enterotoxigenic , E. coli, Transcutaneous vaccine, Safety, Immunogenicity, LT(R192G)

Journal

VACCINE

Volume 38, Issue 45, Pages 7040-7048

Publisher

Elsevier BV

Online

2020-09-23

DOI

10.1016/j.vaccine.2020.09.025

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started